Products
16314 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General Motors Constant Leverage with ISIN code: CH1423416242 | General Motors | Constant Leverage | Long | ― | 79.853 | 48.6 | 0.450 | 49.05 | 1 | -0.92% | -27.15% | -40.78% | 7 May. 2025 | |
| General Motors Constant Leverage with ISIN code: CH1362351459 | General Motors | Constant Leverage | Short | ― | 79.853 | 0.27 | 0.010 | 0.28 | 1 | -3.57% | 12.50% | -6.90% | 6 Nov. 2024 | |
| General Motors Constant Leverage with ISIN code: CH1450969139 | General Motors | Constant Leverage | Short | ― | 79.853 | 0.15 | 0.010 | 0.16 | 1 | -6.25% | 15.38% | -21.05% | 21 Aug. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1119068364 | Genmab | Constant Leverage | Long | ― | 1,890.214 | 0.4 | 0.030 | 0.43 | 1 | -6.98% | -18.37% | -51.81% | 18 May. 2022 | |
| Genmab Constant Leverage with ISIN code: CH1235293474 | Genmab | Constant Leverage | Long | ― | 1,890.214 | 0.14 | 0.020 | 0.16 | 1 | -12.50% | -22.22% | -53.33% | 10 Jan. 2023 | |
| Genmab Constant Leverage with ISIN code: CH1450969170 | Genmab | Constant Leverage | Long | ― | 1,890.214 | 15.76 | 0.340 | 16.1 | 1 | -2.11% | -21.63% | -70.40% | 21 Aug. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1423417562 | Genmab | Constant Leverage | Long | ― | 1,890.214 | 7.71 | 0.230 | 7.94 | 1 | -2.90% | -28.54% | -84.03% | 13 Jun. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1450969451 | Genmab | Constant Leverage | Long | ― | 1,890.214 | 6.89 | 0.150 | 7.04 | 1 | -2.13% | -21.62% | -70.39% | 15 Sep. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1119068372 | Genmab | Constant Leverage | Short | ― | 1,890.214 | 0.5 | 0.030 | 0.53 | 1 | -5.66% | 6.38% | 31.58% | 18 May. 2022 | |
| Genmab Constant Leverage with ISIN code: CH1345999051 | Genmab | Constant Leverage | Short | ― | 1,890.214 | 0.29 | 0.030 | 0.32 | 1 | -9.38% | 3.57% | 31.82% | 18 Apr. 2024 | |
| Genmab Constant Leverage with ISIN code: CH1396328994 | Genmab | Constant Leverage | Short | ― | 1,890.214 | 0.1 | 0.030 | 0.13 | 1 | -23.08% | 12.36% | 42.86% | 12 Feb. 2025 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1119067762 | Gilead Sciences | Constant Leverage | Long | ― | 155.824 | 42.76 | 0.070 | 42.83 | 1 | -0.16% | 13.60% | 131.39% | 11 May. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1197223048 | Gilead Sciences | Constant Leverage | Long | ― | 155.824 | 21.25 | 0.050 | 21.3 | 1 | -0.23% | 18.65% | 236.23% | 24 Jun. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1197223055 | Gilead Sciences | Constant Leverage | Long | ― | 155.824 | 2.35 | 0.010 | 2.36 | 1 | -0.42% | 21.76% | 351.92% | 24 Jun. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1450968131 | Gilead Sciences | Constant Leverage | Short | ― | 155.824 | 0.32 | 0.010 | 0.33 | 1 | -3.03% | -31.91% | -82.22% | 9 Jul. 2025 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1450968149 | Gilead Sciences | Constant Leverage | Short | ― | 155.824 | 1.19 | 0.010 | 1.2 | 1 | -0.83% | -20.67% | -67.04% | 9 Jul. 2025 | |
| Givaudan Constant Leverage with ISIN code: CH1197221224 | Givaudan | Constant Leverage | Long | ― | 3,081.33 | 0.29 | 0.030 | 0.32 | 1 | -9.38% | -12.12% | -38.30% | 15 Jun. 2022 | |
| Givaudan Constant Leverage with ISIN code: CH1119066574 | Givaudan | Constant Leverage | Long | ― | 3,081.33 | 1.08 | 0.030 | 1.11 | 1 | -2.70% | -3.57% | -21.17% | 27 Apr. 2022 | |
| Givaudan Constant Leverage with ISIN code: CH1423416499 | Givaudan | Constant Leverage | Long | ― | 3,081.33 | 0.004 | ― | ― | 1 | 0.00% | 0.00% | -82.61% | 12 May. 2025 | |
| Givaudan Constant Leverage with ISIN code: CH1450968792 | Givaudan | Constant Leverage | Short | ― | 3,081.33 | 7.31 | 0.400 | 7.71 | 1 | -5.19% | -9.42% | -12.35% | 21 Aug. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.